AstraZeneca Crestor Plan: Drop 80 Mg, Submit Lower-Dose Data In Q1
AstraZeneca's updated Crestor NDA will focus on doses of 40 mg and lower following a decision not to seek approval for the 80 mg strength of the cholesterol drug
AstraZeneca's updated Crestor NDA will focus on doses of 40 mg and lower following a decision not to seek approval for the 80 mg strength of the cholesterol drug